|
|
Post by lennymnkd on Aug 30, 2018 14:04:37 GMT -5
|
|
|
|
Post by peppy on Aug 30, 2018 14:14:43 GMT -5
this is the reason Mike C decided on Treprostinil. |
|
|
|
Post by brotherm1 on Aug 30, 2018 14:32:59 GMT -5
why is it the reason he decided on Trepostinil?
|
|
|
|
Post by peppy on Aug 30, 2018 14:36:30 GMT -5
why is it the reason he decided on Trepostinil? MNKD got some input from the FDA regarding Trepostinil, the input I believe is/was fast track. |
|
|
|
Post by brotherm1 on Aug 30, 2018 14:40:06 GMT -5
I thought you might be implying that. Though comsidering our share price needs a boost, I would think he would have told us if the FDA said so. Seeing that he has not, has me confused as to why we are not in the fast lane with it.
|
|
|
|
Post by peppy on Aug 30, 2018 14:42:15 GMT -5
I thought you might be implying that. Though comsidering our share price needs a boost, I would think he would have told us if the FDA said so. Seeing that he has not, has me confused as to why we are not in the fast lane with it. he did tell us, on one of the conference calls. When they decided to pursue treprostinil. This information/belief, did not come to me through osmosis. |
|
|
|
Post by brotherm1 on Aug 30, 2018 14:44:20 GMT -5
Trepostinil yes, he did say, but not Epi. Why is our Epi not being fast tracked?
|
|
|
|
Post by peppy on Aug 30, 2018 14:45:58 GMT -5
Trepostinil yes, he did say, but not Epi. Why is our Epi not being fast tracked? did you see Epi had news today? Epi is around. trepostinil more of a need. (?) |
|
|
|
Post by brotherm1 on Aug 30, 2018 14:49:27 GMT -5
Did you see Insys stock up 35% today?  Epi stil has big demand. We should have both Epi and Trep being fast tracked. |
|
|
|
Post by mnholdem on Aug 30, 2018 14:57:56 GMT -5
TEVA recently got FDA approval on generic Epi pen, didn’t they? |
|
|
|
Post by mannmade on Aug 30, 2018 16:21:21 GMT -5
Yes
|
|
|
|
Post by Omega on Aug 30, 2018 16:28:46 GMT -5
Did you see Insys stock up 35% today? Epi stil has big demand. We should have both Epi and Trep being fast tracked. I'd assume that pursuing two additional Drugs would cost more then one. Treprostinil is already being Inhaled currently so its less of a paradigm shift (uphill battle). |
|
|
|
Post by traderdennis on Aug 30, 2018 17:15:56 GMT -5
Trepostinil yes, he did say, but not Epi. Why is our Epi not being fast tracked? Because the generic EPI pen was approved by the FDA for TEVA |
|
|
|
Post by tomtabb on Aug 30, 2018 20:00:00 GMT -5
Trepostinil yes, he did say, but not Epi. Why is our Epi not being fast tracked? Because the generic EPI pen was approved by the FDA for TEVA Mannkind said it was "aggressively moving forward" with TS-epi over a year and a half ago. If they had, they could have gotten approval far ahead of Teva and Insys. |
|
|
|
Post by peppy on Aug 30, 2018 20:04:25 GMT -5
Because the generic EPI pen was approved by the FDA for TEVA Mannkind said it was "aggressively moving forward" with TS-epi over a year and a half ago. If they had, they could have gotten approval far ahead of Teva and Insys. MNKD EPI is available for license. #tag team |
|
Epi stil has big demand. We should have both Epi and Trep being fast tracked. 
